EGFR and inflammatory breast carcinoma: EGFR mutations (e.g., EGFR exon 19: 55,242,465–55,242,479) were also observed in IBC patients compared to non-IBC patients (FDR p-value = 0.00894 for TN-IBC and FDR p-value = 0.023 for ER+ IBC).